1998
DOI: 10.1016/s0272-6386(98)70055-1
|View full text |Cite
|
Sign up to set email alerts
|

Tuberculosis infection and anergy in hemodialysis patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
62
2
1

Year Published

2001
2001
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 103 publications
(69 citation statements)
references
References 12 publications
4
62
2
1
Order By: Relevance
“…Previous studies have suggested high rates of anergy to TST among ESRD patients (8,9). This is the first study, to our knowledge, that has assessed the ability of IFN-␥ assays to detect recent TB infection in renal dialysis patients.…”
Section: Discussionmentioning
confidence: 84%
See 1 more Smart Citation
“…Previous studies have suggested high rates of anergy to TST among ESRD patients (8,9). This is the first study, to our knowledge, that has assessed the ability of IFN-␥ assays to detect recent TB infection in renal dialysis patients.…”
Section: Discussionmentioning
confidence: 84%
“…Their underlying immune suppression raises the likelihood of false-negative TB skin test (TST) results and makes interpretation of negative results unreliable. Dialysis patients have been shown to have significant rates of cutaneous anergy to antigens, such as Candida, mumps, or tetanus (8,9). Furthermore, as in immunocompetent populations, the TST can be falsely positive in persons with a history of previous nontuberculous mycobacterium infection or vaccination with bacillus Calmette-Guerin (BCG) (10).…”
mentioning
confidence: 99%
“…The prevalence of latent TB infection in ESRD patients varies from 11% to 63% using the tuberculin skin test (TST) (12)(13)(14). The TST may grossly underestimate the prevalence because of the high rates of cutaneous anergy (up to 44%) (10,(15)(16)(17) and is limited by a low specificity, with cross-reactions to Bacille-Calmette-Guérin (BCG) vaccination and exposure to nontuberculous mycobacteria.…”
mentioning
confidence: 99%
“…Our study provides a direct proof for the clinical notion that IGRAs are of higher sensitivity to detect a specific immune response as compared to the TST, particularly in immunocompromised patients (4,8,(13)(14)(15)(16). Unlike the TST, IGRAs were more closely associated with clinically assessable variables consistent with prior contact with mycobacterial antigens such as history of active tuberculosis, prior exposure to M. tuberculosis, long-term residence in a M. tuberculosis-endemic country or BCG vaccination.…”
Section: Discussionmentioning
confidence: 56%